Key facts
- This page summarizes John F. Thero's Form 4 filing for AMARIN CORP PLC\UK (AMRN).
- 7 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 03 Aug 2021, 20:02.
John F. Thero - 30 Jul 2021 Form 4 Insider Report for AMARIN CORP PLC\UK (AMRN)
- Reporting relationship
- President and CEO, Director
- Issuer ticker
- AMRN
- Reported as of
- 30 Jul 2021
- Net transaction value
- -$43,901
- SEC form
- 4
- Accepted by SEC
- 03 Aug 2021, 20:02:27 UTC
- Prior SEC filing
- 02 Jul 2021
- Next SEC filing
- 05 Aug 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael W. Kalb, by power of attorney
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
John F. Thero filed Form 4 for AMARIN CORP PLC\UK (AMRN) on 03 Aug 2021.
Change
- Previous filing in this sequence was filed on 02 Jul 2021.
- Current net transaction value: -$43,901.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AMRN
transaction
Ordinary Shares
Options Exercise
- Transaction value
- Shares
- +6,736
- Change %
- +0.21%
- Price
- Shares after
- 3,243,148
- Date
- 30 Jul 2021
- Ownership
- Direct
- Footnotes
- F1, F2, F3
AMRN
transaction
Ordinary Shares
Options Exercise
- Transaction value
- Shares
- +6,736
- Change %
- +0.21%
- Price
- Shares after
- 3,249,884
- Date
- 30 Jul 2021
- Ownership
- Direct
- Footnotes
- F1, F2, F3
AMRN
transaction
Ordinary Shares
Options Exercise
- Transaction value
- Shares
- +13,472
- Change %
- +0.41%
- Price
- Shares after
- 3,263,356
- Date
- 30 Jul 2021
- Ownership
- Direct
- Footnotes
- F1, F2, F3
AMRN
transaction
Ordinary Shares
Tax liability
- Transaction value
- $43,901
- Shares
- -10,604
- Change %
- -0.32%
- Price
- $4.14
- Shares after
- 3,252,752
- Date
- 30 Jul 2021
- Ownership
- Direct
- Footnotes
- F1, F4, F5
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AMRN
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -6,736
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 6,736
- Date
- 30 Jul 2021
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 6,736
- Exercise price
- $0.000000
- Footnotes
- F1, F2, F3, F6
AMRN
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -6,736
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 6,736
- Date
- 30 Jul 2021
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 6,736
- Exercise price
- $0.000000
- Footnotes
- F1, F2, F3, F6
AMRN
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -13,472
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 13,472
- Date
- 30 Jul 2021
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 13,472
- Exercise price
- $0.000000
- Footnotes
- F1, F2, F3, F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
John F. Thero is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 6 footnotes
Footnote F1
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
Footnote F2
As previously reported on February 27, 2020 and March 1, 2021, on May 15, 2017, the Reporting Person was granted 970,000 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2011 Stock Incentive Plan, of which the performance criteria related to two tranches representing 25% of the total award each was deemed achieved on February 25, 2020 pursuant to reporting of audited net product revenues for 2019 exceeding $400 million and of which the performance criteria related to one tranche representing 50% of the total award was deemed achieved on February 25, 2021 pursuant to reporting of audited net product revenues for 2020 exceeding $500 million. The tranches vest ratably over 36 months beginning September 30, 2018 subject to achievement of the performance criteria and continued service of the Reporting Person as provided in the RSU Award Agreement between the Issuer and Reporting Person. The thirty-fifth vesting event occurred on July 30, 2021.
Footnote F3
Not applicable.
Footnote F4
Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities.
Footnote F5
Please see the section titled "Remarks" below for additional information.
Footnote F6
Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion.
SEC remarks
In the case of a Change of Control (as defined in the Issuer's stock incentive plan), the grants described in this Form 4 vest in full. As of the date of this Form 4, the Reporting Person owns or holds the right to acquire an aggregate of 10,462,395 Ordinary Shares of the Issuer in the form of Ordinary Shares, stock options and RSUs outstanding under the Issuer's stock incentive plans, including but not limited to certain performance-based RSUs that are earned only if certain pre-defined operational milestones are achieved and, in certain cases, then vest only if the recipient remains with the company for an extended period of time.